EULAR 2021  | congress satellite symposia

A number of satellite symposia virtual events will be organized during EULAR 2021 CONGRESS from 2 June 2021. The program will be updated on this page.

Satellite symposia are governed by EULAR Guidelines. Symposia are strictly prohibited during the official program hours. All symposia and special events must be approved by EULAR.

PROGRAMME OVERVIEW *
 

WEDNESDAY 2 JUNE 2021

18:15 - 19:45 Satellite symposia

THURSDAY 3 JUNE 2021

08:15 - 09:45 Satellite symposia
17:30 - 19:00  Satellite symposia

FRIDAY 4 JUNE 2021

08:15 - 09:45 Satellite symposia
17:30 - 19:00 Satellite symposia


View full industry programme

SATELLITE SYMPOSIA PROGRAMME 2021

02 June | 18:15 - 19:45 CEST | Satellite Symposia
Lilly - Exploring Global Olumiant Experience in Treating Rheumatoid Arthritis: Different Continents, Different Circumstances
Speaker (s): Various 

Session details 

02 June | 18:15 - 19:45 CEST | Satellite Symposia
Pfizer - JAK Inhibitors in RA: What, Where, How, Why, Who and When?
Speaker (s): Various 

session details 

02 June | 18:15 - 19:45 CEST | Satellite Symposia
Novartis - Reimagining the standard of care in PsA and axSpA
Speaker (s): Various 

Session details 

02 June | 18:15 - 19:45 CEST | Satellite Symposia
AbbVie - A practical guide to use of JAK inhibitors in management of RA and SpA
Speaker (s): Various 

Session details 

02 June | 18:15 - 19:45 CEST | Satellite Symposia
UCB - The Evolving Understanding of the Pathobiology of Axial Spondyloarthritis and Psoriatic Arthritis
Speaker (s): Various 

Session details 

02 June | 18:15 - 19:45 CEST | Satellite Symposia
Galapagos - In Darwin's footsteps: continuing evolution of RA patient care as we adapt to a changing environment
Speaker (s): Various 

Session details 

02 June | 18:15 - 19:45 CEST | Satellite Symposia
Janssen - To see is to believe? Guidance on using imaging to optimize patient care in psoriatic arthritis
Speaker (s): Various

Session details


03 June | 08:15 - 09:45 CEST | Satellite Symposia
Pfizer - Targeting the Immunopathogenesis of Ankylosing Spondylitis: Emerging Treatment Options
Speaker (s):
Various 
Session details 

03 June | 08:15 - 09:45 CEST | Satellite Symposia
Celltrion Healthcare - Management of rheumatic diseases during the COVID-19 pandemic
Speaker (s):
Various 
Session details

03 June | 08:15 - 09:45 CEST | Satellite Symposia
Medac - Methotrexate - how to use the gold standard the optimized way in RA therapy
Speaker (s):
Various 
session details

03 June | 08:15 - 09:45 CEST | Satellite Symposia
Novartis - Reimagining patient care and future directions in axSpA and PsA
Speaker (s):
Various 
Session details

03 June | 08:15 - 09:45 CEST | Satellite Symposia
Abbvie - COVID-19 and the Management of Patients with Rheumatic Musculoskeletal Diseases
Speaker (s):
Various 
Session details

03 June | 08:15 - 09:45 CEST | Satellite Symposia
R-Pharm - Targeting IL-6 ligand - exploring a novel treatment option with a focus on olokizumab
Speaker (s):
Various 
Session details

03 June | 08:15 - 09:45 CEST | Satellite Symposia
BMS - TYK Talk: Discover a New Class of Oral Small Molecules in Development Targeting TYK2
Speaker (s):
Various 
Session details

03 June | 08:15 - 09:45 CEST | Satellite Symposia
Amgen - Patient perspectives in moderate PsA: How tailored treatment can improve the patient experience
Speaker (s):
Various
Session details

03 June | 17:30 - 19:00 CEST | Satellite Symposia
Lilly - Up-to-date treatment of spondyloarthritis: Innovation becoming standard of care
Speaker (s):
Various 
Session details

03 June | 17:30 - 19:00 CEST | Satellite Symposia
GSK - Contemporary Treatment Targets in SLE: The Journey to Disease Control
Speaker (s):
Various 
Session details

03 June | 17:30 - 19:00 CEST | Satellite Symposia
Mind the gap - balancing remission and risk of relapse in AAV
Speaker (s):
Various 
Session details

03 June | 17:30 - 19:00 CEST | Satellite Symposia
UCB - A Guide to axSpA: From Symptoms to Outcomes
Speaker (s):
Various 
Session details

03 June | 17:30 - 19:00 CEST | Satellite Symposia
BMS - Understanding and Influencing the Disease Trajectory of Rheumatoid Arthritis
Speaker (s):
Various 
Session details

03 June | 17:30 - 19:00 CEST | Satellite Symposia
Janssen - The launching pad: exploring the potential of the IL-23 pathway in PsA
Speaker (s):
Various
Session details

03 June | 17:30 - 19:00 CEST | Satellite Symposia
Galapagos - In Darwin’s footsteps: exploring the role of JAK inhibitors within the diverging RA treatment landscape
Speaker (s):
Various
Session details

03 June | 17:30 - 19:00 CEST | Satellite Symposia
Boehringer Ingelheim - Rheumatoid Arthritis and the Lung: Think Outside the Joint

Speaker (s):
Various
Session details



04 June | 08:15 - 09:45 CEST | Satellite Symposia
Amgen - Artificial intelligence in rheumatic diseases: can it solve the treatment management puzzle?
Speaker (s): Various 

session details

04 June | 08:15 - 09:45 CEST | Satellite Symposia
International Medical Press - Weight management that works in osteoarthritis
Speaker (s):
Various 
Session details

04 June | 08:15 - 09:45 CEST | Satellite Symposia
Fresenius Kabi - The long and winding road: Caring for patients with inflammatory rheumatic conditions
Speaker (s):
Various 
session details

04 June | 08:15 - 09:45 CEST | Satellite Symposia
Roche - Mission: Possible - novel anti-CD20 promise for lupus nephritis?
Speaker (s):
Various 
session details

04 June | 08:15 - 09:45 CEST | Satellite Symposia
Abbvie - Striving for remission with JAK inhibition in the management of rheumatoid arthritis
Speaker (s):
Various 
Session details

04 June | 08:15 - 09:45 CEST | Satellite Symposia
GSK - Eosinophil-driven diseases: An unmet need and clinical challenge
Speaker (s):
Various
Session details

04 June | 08:15 - 09:45 CEST | Satellite Symposia
Boehringer Ingelheim - Management of SSc-ILD: using evidence in clinical practice
Speaker (s):
Various
Session details


04 June | 17:30 - 19:00 CEST | Satellite Symposia
Pfizer - Exploring Advanced Therapeutic Options in PsA: A Domain-Driven Approach
Speaker (s):
Various
Session details

04 June | 17:30 - 19:00 CEST | Satellite Symposia
Vifor - Striking the right balance in ANCA-associated vasculitis (AAV)
Speaker (s):
Various
session details

04 June | 17:30 - 19:00 CEST | Satellite Symposia
AstraZeneca - Transforming SLE: optimizing care for patients with lupus
Speaker (s):
Various
session details

04 June | 17:30 - 19:00 CEST | Satellite Symposia
GSK - What's next for patients with Lupus Nephritis?
Speaker (s):
Various
session details

04 June | 17:30 - 19:00 CEST | Satellite Symposia
AbbVie - Transforming management in SpA: Integrating novel oral approaches in clinical practice
Speaker (s):
Various
Session details

04 June | 17:30 - 19:00 CEST | Satellite Symposia
CSF - Cytokine Signaling Blockade: Interactions and Outcomes (Supported by Lilly)
Speaker (s):
Various
Session details

04 June | 17:30 - 19:00 CEST | Satellite Symposia
Janssen - Addressing key challenges of pulmonary arterial hypertension in CTD patients: Multidisciplinary approach, a formula for success
Speaker (s):
Various
Session details



* CEST (Central European Summer time)